Placebo-Controlled, Sequential Group, Single Dose, Dose-Escalation Study to Evaluate the Safety and PK of ETI-204

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Elusys Therapeutics
ClinicalTrials.gov Identifier:
NCT01453907
First received: October 14, 2011
Last updated: May 22, 2013
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)